×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Pfizer taps Deutsch for Zyrtec

Published on .

Pfizer, New York, has awarded Deutsch, New York the estimated $75 million account for its anti-allergy drug Zyrtec. Deutsch bested McCann-Erickson Worldwide, Merkley Newman Harty and Ogilvy & Mather Worldwide, all New York, to win the account. The previous agency was HMC, New York. Advice & Advisors, New York, consulted on the review.

Copyright August 1999, Crain Communications Inc.

In this article:
Most Popular